Literature DB >> 7447414

Tetracycline transport in Bacteroides fragilis.

F Fayolle, G Privitera, M Sebald.   

Abstract

In susceptible strain of Bacteroides fragilis, tetracycline uptake is biphasic. The initial phase is independent of adenosine 5'-triphosphate synthesis, which is coupled to fumarate reduction; this phase is not altered by expression of tetracycline resistance genes in a resistant strain. The second phase appears to occur by active transport, since it is largely reduced by rotenone, an inhibitor of electron transport to fumarate; moreover, this phase is under negative control of the tetracycline resistance gene.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7447414      PMCID: PMC284038          DOI: 10.1128/AAC.18.4.502

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Hydrogenase activity and the H2-fumarate electron transport system in Bacteroides fragilis.

Authors:  M A Harris; C A Reddy
Journal:  J Bacteriol       Date:  1977-09       Impact factor: 3.490

2.  Plasmid-determined tetracycline resistance involves new transport systems for tetracycline.

Authors:  S B Levy; L McMurry
Journal:  Nature       Date:  1978-11-02       Impact factor: 49.962

3.  Two transport systems for tetracycline in sensitive Escherichia coli: critical role for an initial rapid uptake system insensitive to energy inhibitors.

Authors:  L McMurry; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

4.  Common regulatory mechanism of expression and conjugative ability of a tetracycline resistance plasmid in Bacteroides fragilis.

Authors:  G Privitera; M Sebald; F Fayolle
Journal:  Nature       Date:  1979-04-12       Impact factor: 49.962

5.  Evidence for cytochrome involvement in fumarate reduction and adenosine 5'-triphosphate synthesis by Bacteroides fragilis grown in the presence of hemin.

Authors:  J Macy; I Probst; G Gottschalk
Journal:  J Bacteriol       Date:  1975-08       Impact factor: 3.490

6.  Bacterial resistance to the tetracyclines.

Authors:  I Chopra; T G Howe
Journal:  Microbiol Rev       Date:  1978-12

7.  Accumulation of tetracyclines by Escherichia coli.

Authors:  J R De Zeeuw
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

8.  Pathway of succinate and propionate formation in Bacteroides fragilis.

Authors:  J M Macy; L G Ljungdahl; G Gottschalk
Journal:  J Bacteriol       Date:  1978-04       Impact factor: 3.490

  8 in total
  7 in total

1.  Macrolide accumulation by Bacteroides fragilis ATCC 25285.

Authors:  Y Muto; K Bandoh; K Watanabe; N Katoh; K Ueno
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

2.  Streptococcal tetracycline resistance mediated at the level of protein synthesis.

Authors:  V Burdett
Journal:  J Bacteriol       Date:  1986-02       Impact factor: 3.490

Review 3.  Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria.

Authors:  T J Foster
Journal:  Microbiol Rev       Date:  1983-09

4.  Cryptic tetracycline resistance determinant (class F) from Bacteroides fragilis mediates resistance in Escherichia coli by actively reducing tetracycline accumulation.

Authors:  B H Park; M Hendricks; M H Malamy; F P Tally; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

5.  A tetracycline efflux gene on Bacteroides transposon Tn4400 does not contribute to tetracycline resistance.

Authors:  B S Speer; A A Salyers
Journal:  J Bacteriol       Date:  1990-01       Impact factor: 3.490

6.  Transposon Tn10-like tetracycline resistance determinants in Haemophilus parainfluenzae.

Authors:  S B Levy; A Buu-Hoi; B Marshall
Journal:  J Bacteriol       Date:  1984-10       Impact factor: 3.490

7.  Limitations of a fluorescence assay for studies on tetracycline transport into Escherichia coli.

Authors:  M C Smith; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.